Different profiles and epidemiological scenarios: past, present and future

Area of Science:

• * Infectious Diseases
• * Epidemiology
• * Public Health

Background:

• * Chagas disease (American Trypanosomiasis) exhibits complex epidemiological patterns influenced by multiple transmission routes and diverse geo-ecobiosocial settings.
• * The understanding of disease dynamics has evolved significantly since Carlos Chagas's initial description in 1909, revealing increasing complexity over time and geography.
• * Global dispersion of Trypanosoma cruzi, various transmission pathways, curability of infection, and the expanded geographic range of triatomine vectors highlight the evolving paradigms.

Purpose of the Study:

• * To analyze the multifaceted epidemiological scenarios of Chagas disease.
• * To explore the impact of different Trypanosoma cruzi transmission routes, including those with and without triatomine vector involvement.
• * To examine scenarios involving vectors present without the parasite and discuss future prospects for disease management.

Main Methods:

• * Review and synthesis of existing epidemiological data and scientific literature on Chagas disease.
• * Analysis of transmission routes, including vector-borne, congenital, oral, and blood transfusion pathways.
• * Consideration of geographic spread, vector distribution, and human movement patterns.

Main Results:

• * Chagas disease epidemiology is characterized by a multiplicity of scenarios, complicating control efforts.
• * Trypanosoma cruzi infection has demonstrated global dispersion, challenging previous assumptions about its geographic limitations.
• * The disease can be transmitted through various routes, and importantly, the infection is curable, and triatomine vectors pose a threat beyond Latin America.

Conclusions:

• * The complexity of Chagas disease epidemiology necessitates adaptive and multifaceted control strategies.
• * Continued research into transmission dynamics, early diagnosis, and treatment is essential for mitigating the global burden of American Trypanosomiasis.
• * Addressing the evolving scenarios, including non-vector-borne transmission and geographic expansion, is critical for future public health interventions.